Medistep Healthcare Limited
NNSE:MEDISTEP21.40
INR
+0.40
(+1.90%)
Medistep Healthcare Limited
NSE:MEDISTEP
(National Stock Exchange of India)
Recent
price
21.40
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Medistep Healthcare Limited is an India-based pharmaceutical and healthcare company engaged in the manufacturing, marketing, distribution, and supply of pharmaceutical formulations, medical consumables, nutraceuticals, and healthcare solutions. The company operates through three primary business divisions: Finished Dosage Formulations, Medical and Surgical Consumables, and Consumer Healthcare and Nutraceuticals. Its product portfolio comprises prescription and generic pharmaceutical formulations across therapeutic segments including anti-infectives, analgesics, antipyretics, cardiovascular agents, gastrointestinal therapies, respiratory medications, and anti-diabetic treatments, offered in solid and liquid dosage forms such as oral tablets, hard and soft gelatin capsules, pediatric syrups, suspensions, dry powders, and injectable solutions; medical disposables and surgical supplies, including sterile surgical gloves, single-use syringes, intravenous infusion sets, diagnostic test kits, surgical tapes, wound dressings, and catheterization products; and nutraceutical supplements and wellness products, including daily multivitamin complexes, mineral formulations, herbal health supplements, immunity boosters, and nutritional protein powders. Medistep Healthcare caters to government and private hospitals, institutional healthcare providers, pharmacy chains, retail chemists, clinical laboratories, and regional distributors across India and emerging export markets. In recent corporate developments, the company executed its initial public offering and listed its equity shares on the National Stock Exchange of India (NSE: MEDISTEP) to fund working capital requirements, upgrade logistics infrastructure, and support business expansion. Over the past two years, Medistep Healthcare has entered into multi-regional supply partnerships with major hospital networks, expanded its third-party contract manufacturing agreements, commissioned upgraded warehousing and cold-chain distribution hubs across tier-2 and tier-3 markets, and launched an advanced product line of chronic disease management and preventive wellness formulations. Founded in 2012 and headquartered in Mumbai, India, Medistep Healthcare Limited operates through an extensive distribution and marketing network across domestic and international territories.